| Class | Dopamine receptor antagonist |
|---|---|
| Chemistry |
Phenothiazine |
| Routes of administration |
Oral, IV, IM, s/c |
| Absorption |
Poor oral bioavailability, 12.5% |
| Solubility |
pKa 8.39, only slightly soluble in water |
| Distribution |
VOD=22L/kg, highly protein bound (up to 99%) |
| Metabolism |
Extensively metabolised by the liver into inactive metabolites |
| Elimination |
Clearance is almost completely hepatic; only soome minimal amount is eliminated by the kidneys |
| Time course of action |
Half-life is 4-8 hours, which corresponds with the duration of effect |
| Target receptor |
All phenothiazines are competitive antagonists of multiple receptors: |
| Mechanism of action |
Multiple mechanisms of action: |
| Clinical effects |
#NAME? |
| Literature reference |
Isah et al, 1991 |
| CICM details of understanding | Level 3 |
| Mentioned around Deranged Physiology | |
| Related SAQs |
|